Viewing Study NCT01598103

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 7:35 PM
Ignite Modification Date: 2026-05-17 @ 6:33 PM
Study NCT ID: NCT01598103
Status: TERMINATED
Last Update Posted: 2020-12-19
First Post: 2012-02-17
Is Gene Therapy: True
Has Adverse Events: False
Brief Title: Safety and Efficacy of SAF312 in Patients With Neurogenic Detrusor Overactivity Due to Spinal Cord Lesions
Sponsor: Novartis Pharmaceuticals
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Neurogenic Urinary Bladder View
None Neurogenic Bladder Disorder View
None Neurogenic Dysfunction of the Urinary Bladder View
None Neurogenic Bladder, Uninhibited View
None Neurogenic Bladder, Spastic View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Neurogenic detrusor overactivity View
None spinal cord lesions View
None spinal cord injury View